The aims of this study were: (i) to compare the performance of two ELISAs, IP and LB for detection of anti-TIF1-gamma autoantibodies in patients with DM, and (ii) to compare the potential of these assays to identify anti-TIF1-gamma-positive CADM. The gene discussed is TRIM33; the disease is dermatomyositis.